A double-blind, randomized, placebo-controlled study to assess the safety and efficacy of nebulized PC945 when added to systemic antifungal therapy for the treatment of refractory invasive pulmonary aspergillosis

Project: Research

Project Details

StatusFinished
Effective start/end date23/01/24 → 23/01/26

Keywords

  • clinical trial
  • pulmonary aspergillosis
  • antifungal therapy
  • PC945

Clinical Trial Phase

  • Phase III (a & b)